It will feature a customer collaboration laboratory and training center as well as office space.
The facility will house a customer service, a call center and an M Lab collaboration center, allowing the company's scientists and engineers to meet their stringent biomanufacturing challenges.
The M Lab collaboration center will replace the M Lab at the company's Billerica facility. Hands-on training, customer experiments and application troubleshooting will be carried out at the center in a non-GMP environment.
The Gutierrez Company is building the Burlington facility, which is expected to be completed in the second half of 2017.
MilliporeSigma CEO and Merck executive board member Udit Batra said: "This new and more expansive MilliporeSigma campus gives us a unique, multi-use life science hub in the United States—one that provides our employees and customers with a sustainable and collaborative working environment.”
The project has an option to expand an additional 70,000 square feet. Merck, whose life science business operates as MilliporeSigma in the US and Canada, leases the property.
MilliporeSigma will maintain its other North American life science hub in St. Louis, Missouri.
Merck’s life science business employs 19,000 people in 65 manufacturing sites globally. It has a portfolio of over 300,000 products allowing scientific discovery.
Image: MilliporeSigma's Burlington, Massachusetts campus will serve as a major life science hub for Merck. Photo: courtesy of PRNewsFoto/MilliporeSigma.